Skip to Main Content

Paper Details

Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER.
Br J Ophthalmol
0
2024
Brolucizumab, Diabetic Retinopathy, aflibercept, brolucizumab, nAMD, neovascular age-related macular degeneration, patients
Author NameAffiliation
SriniVas R SaddaDoheny Eye Institute, University of California los angeles
David SarrafJules Stein Eye Institute, university of california los angeles
David SarrafJules Stein Eye Institute, university of california los angeles
  • 1 - 3

Datasets

Release 1.2